Cas:4594-77-8 3-(2-Oxocyclopentyl)propanenitrile manufacturer & supplier

We serve Chemical Name:3-(2-Oxocyclopentyl)propanenitrile CAS:4594-77-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-(2-Oxocyclopentyl)propanenitrile

Chemical Name:3-(2-Oxocyclopentyl)propanenitrile
CAS.NO:4594-77-8
Synonyms:2-oxo-cyclopentanepropanenitrile;EINECS 224-990-0;2-Oxocyclopentanepropiononitrile;3-(2-oxo-cyclopentyl)-propionitrile;2-(2-cyanoethyl)-cyclopentanone;3-(2-Oxo-cyclopentyl)-propionitril;2-cyanoethylcyclopentanone;Cyclopentanepropanenitrile,2-oxo
Molecular Formula:C8H11NO
Molecular Weight:137.17900
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:285.2ºC at 760mmHg
Density:1.033g/cm3
Index of Refraction:1.47
PSA:40.86000
Exact Mass:137.08400
LogP:1.65938

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2-oxo-cyclopentanepropanenitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Cyclopentanepropanenitrile,2-oxo physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(2-oxo-cyclopentyl)-propionitrile Use and application,2-cyanoethylcyclopentanone technical grade,usp/ep/jp grade.


Related News: These sites operate under cGMP conditions and have been inspected and approved by leading global pharmaceutical companies and regulatory authorities, including the US FDA. N-(2-(3-((ethyl(6-methoxy-6-methylhepta-2,4-diyn-1-yl)amino)methyl)phenoxy)ethyl)-N-methylthiophene-2-sulfonamide manufacturers Alexion has been working to push Ultomiris through additional indications ahead of Soliris’ expected loss of exclusivity in 2025. (E)-3-Methoxy-dec-2-en-9-olid suppliers Biogen hiked its revenue guidance for the year, saying it expects total sales of $10.65 billion to $10.85 billion this year. That’s up from its previous estimates of $10.45 billion to $10.75 billion. The new forecast assumes “modest” revenue from Aduhelm in 2021, ramping up thereafter, the company said. (5,5-dimethyl-2-oxo-1,3,2λ(sup)5(/sup)-dioxaphosphinan-2-yl)hydrazine vendor & factory.